Andra AP-fonden’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.9M | Sell |
245,573
-771,627
| -76% | -$20.5M | 0.08% | 248 |
|
|
2025
Q4 | $25.3M | Buy |
1,017,200
+20,500
| +2% | +$517K | 0.31% | 93 |
|
|
2025
Q3 | $25.4M | Buy |
996,700
+180,600
| +22% | +$4.46M | 0.32% | 111 |
|
|
2025
Q2 | $19.8M | Sell |
816,100
-65,200
| -7% | -$1.52M | 0.28% | 124 |
|
|
2025
Q1 | $22.3M | Buy |
+881,300
| New | +$23.1M | 0.37% | 95 |
|
|
2024
Q2 | – | Sell |
-172,100
| Closed | -$4.78M | – | 440 |
|
|
2024
Q1 | $4.78M | Buy |
+172,100
| New | +$4.78M | 0.08% | 278 |
|
|
2023
Q3 | – | Sell |
-215,100
| Closed | -$7.89M | – | 487 |
|
|
2023
Q2 | $7.89M | Buy |
215,100
+38,900
| +22% | +$1.51M | 0.2% | 199 |
|
|
2023
Q1 | $7.19M | Buy |
176,200
+16,500
| +10% | +$713K | 0.19% | 241 |
|
|
2022
Q4 | $8.18M | Sell |
159,700
-67,400
| -30% | -$3.23M | 0.25% | 125 |
|
|
2022
Q3 | $9.94M | Sell |
227,100
-64,200
| -22% | -$3.12M | 0.33% | 54 |
|
|
2022
Q2 | $15.3M | Buy |
+291,300
| New | +$14.8M | 0.44% | 8 |
|
|
2021
Q4 | $20.7M | Buy |
351,100
+5,200
| +2% | +$258K | 0.42% | 9 |
|
|
2021
Q3 | $14.9M | Sell |
345,900
-28,700
| -8% | -$1.27M | 0.31% | 49 |
|
|
2021
Q2 | $14.7M | Buy |
374,600
+45,400
| +14% | +$1.77M | 0.3% | 50 |
|
|
2021
Q1 | $11.9M | Sell |
329,200
-11,500
| -3% | -$408K | 0.26% | 94 |
|
|
2020
Q4 | $12.5M | Buy |
340,700
+216,539
| +174% | +$7.94M | 0.28% | 59 |
|
|
2020
Q3 | $4.32M | Sell |
124,161
-13,597
| -10% | -$477K | 0.12% | 419 |
|
|
2020
Q2 | $4.27M | Sell |
137,758
-26,455
| -16% | -$899K | 0.12% | 433 |
|
|
2020
Q1 | $5.08M | Buy |
164,213
+17,391
| +12% | +$593K | 0.18% | 172 |
|
|
2019
Q4 | $5.46M | Buy |
146,822
+41,000
| +39% | +$1.46M | 0.16% | 321 |
|
|
2019
Q3 | $3.61M | Buy |
105,822
+633
| +0.6% | +$23K | 0.11% | 497 |
|
|
2019
Q2 | $4.32M | Sell |
105,189
-60,078
| -36% | -$2.39M | 0.12% | 442 |
|
|
2019
Q1 | $6.66M | Buy |
+165,267
| New | +$6.62M | 0.19% | 179 |
|
|
2018
Q3 | $6.4M | Sell |
153,146
-1,054
| -0.7% | -$40.6K | 0.17% | 268 |
|
|
2018
Q2 | $5.31M | Sell |
154,200
-7,589
| -5% | -$259K | 0.14% | 351 |
|
|
2018
Q1 | $5.45M | Sell |
161,789
-589,067
| -78% | -$20.3M | 0.14% | 374 |
|
|
2017
Q4 | $25.8M | Buy |
750,856
+26,114
| +4% | +$890K | 0.59% | 21 |
|
|
2017
Q3 | $24.5M | Buy |
724,742
+27,099
| +4% | +$871K | 0.57% | 22 |
|
|
2017
Q2 | $22.2M | Sell |
697,643
-3,188
| -0.5% | -$101K | 0.55% | 20 |
|
|
2017
Q1 | $22.7K | Sell |
700,831
-9,987
| -1% | -$315K | 0.53% | 22 |
|
|
2016
Q4 | $21.9M | Sell |
710,818
-46,519
| -6% | -$1.42M | 0.6% | 18 |
|
|
2016
Q3 | $24.3M | Buy |
757,337
+21,434
| +3% | +$717K | 0.65% | 18 |
|
|
2016
Q2 | $24.6M | Buy |
735,903
+28,458
| +4% | +$908K | 0.63% | 19 |
|
|
2016
Q1 | $19.9M | Sell |
707,445
-63,978
| -8% | -$1.83M | 0.52% | 34 |
|
|
2015
Q4 | $23.6M | Sell |
771,423
-55,440
| -7% | -$1.74M | 0.67% | 19 |
|
|
2015
Q3 | $24.6M | Buy |
826,863
+949
| +0.1% | +$30.4K | 0.72% | 17 |
|
|
2015
Q2 | $26.3M | Buy |
825,914
+17,918
| +2% | +$584K | 0.76% | 14 |
|
|
2015
Q1 | $26.7M | Sell |
807,996
-225,240
| -22% | -$7.16M | 0.76% | 19 |
|
|
2014
Q4 | $30.5M | Sell |
1,033,236
-223,554
| -18% | -$6.41M | 0.71% | 21 |
|
|
2014
Q3 | $35.3M | Sell |
1,256,790
-202,157
| -14% | -$5.67M | 0.83% | 14 |
|
|
2014
Q2 | $41.1M | Buy |
1,458,947
+56,495
| +4% | +$1.61M | 0.9% | 12 |
|
|
2014
Q1 | $42.7M | Buy |
1,402,452
+109,721
| +8% | +$3.27M | 0.99% | 8 |
|
|
2013
Q4 | $37.6M | Sell |
1,292,731
-74,518
| -5% | -$2.17M | 0.89% | 11 |
|
|
2013
Q3 | $37.2M | Sell |
1,367,249
-261,076
| -16% | -$7.1M | 0.95% | 11 |
|
|
2013
Q2 | $43.3M | Buy |
+1,628,325
| New | +$45M | 1.13% | 7 |
|
Other funds holding PFE
VCM
VPM
Andra AP-fonden's PFE Position: Q1 2026 in Review
Andra AP-fonden reduced its Pfizer (PFE) stake by 76% in Q1 2026, selling an estimated $20.5M and leaving 245,573 shares worth $6.9M. The position accounts for 0.08% of the portfolio, ranked #248.
Andra AP-fonden first reported a position in PFE in Q2 2013 and has held it in 45 quarters since. The position peaked at $43.3M in Q2 2013. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Andra AP-fonden held 245,573 shares of Pfizer worth $6.9M as of Q1 2026.
- Andra AP-fonden sold 771,627 Pfizer shares in Q1 2026, an estimated $20.5M.
- Pfizer made up 0.08% of Andra AP-fonden's portfolio in Q1 2026, its #248 holding.
- Andra AP-fonden first reported a position in Pfizer in Q2 2013 and has held it in 45 quarters since.
- Andra AP-fonden's Pfizer position peaked at $43.3M in Q2 2013.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.